Position in EXEL
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$1,770,066
+$312,450 QoQ
Shares Held
32,532
-4.3% QoQ
Ownership
0.013%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#275
of 751 holders
Holding Since
Mar 2020
20 quarters on record
Voting authority
Sole 6%
Shared 0%
None 94%
Common Shares in EXEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026NewEdge Advisors, LLC holds $47,755,733 across 102 Biotechnology names. EXEL ranks #6 (3.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
18,435 | $9,157,217 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
11,911 | $7,426,984 | |
| 3 | NUVB |
Nuvation Bio Inc.
|
1,231,733 | $6,996,243 | |
| 4 | INCY |
Incyte Corp
|
34,605 | $3,922,822 | |
| 5 | PHAT |
Phathom Pharmaceuticals, Inc.
|
203,962 | $2,212,987 | |
| 6 | EXEL |
Exelixis, Inc.
This page
|
32,532 | $1,770,066 | |
| 7 | BMRN |
Biomarin Pharmaceutical Inc
|
27,287 | $1,561,362 | |
| 8 | RPRX |
Royalty Pharma plc
|
21,597 | $1,210,943 |
All Filings in EXEL
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,770,066 | 32,532 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $1,457,616 | 33,985 | Shares | Sole | 2026-06-03 | |
| 2025-12-31 | $1,651,865 | 37,688 | Shares | Sole | 2026-02-18 | |
| 2025-09-30 | $1,088,296 | 26,351 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $992,946 | 22,526 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $674,085 | 18,258 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $929,336 | 27,908 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $338,673 | 13,051 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $448,860 | 19,976 | Shares | Sole | 2024-08-16 | |
| 2024-03-31 | $704,781 | 29,700 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $673,423 | 28,071 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $423,168 | 19,367 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $370,103 | 19,367 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $155,280 | 8,000 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $7,318 | 8,658 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $178,344 | 11,374 | Shares | Sole | 2022-11-14 | |
| 2020-12-31 | $278,812 | 13,892 | Shares | Sole | 2021-01-27 | |
| 2020-09-30 | $272,397 | 11,141 | Shares | Sole | 2020-11-03 | |
| 2020-06-30 | $436,364 | 18,381 | Shares | Sole | 2020-07-29 | |
| 2020-03-31 | $386,089 | 22,421 | Shares | Sole | 2020-05-04 | |
| No filing history on record for this holder in this stock. | ||||||